External validation of an F-FDG-PET radiomic model predicting survival after radiotherapy for oropharyngeal cancer
Creators
- 1. Department of Medical Physics, San Raffaele Scientific Institute, Milano (Italy)
- 2. Department of Radiotherapy, San Raffaele Scientific Institute, Milano (Italy)
- 3. Department of Medical Physics, Velindre Cancer Centre, Cardiff (United Kingdom)
- 4. School of Engineering, Cardiff University, Cardiff (United Kingdom)
- 5. Vita-Salute San Raffaele University, Milan (Italy)
- 6. Department of Nuclear Medicine, San Raffaele Scientific Institute, Milan (Italy)
Description
The purpose of the study is to externally validate published F-FDG-PET radiomic models for outcome prediction in patients with oropharyngeal cancer treated with chemoradiotherapy. Outcome data and pre-radiotherapy PET images of 100 oropharyngeal cancer patients (stage IV:78) treated with concomitant chemotherapy to 66-69 Gy/30 fr were available. Tumors were segmented using a previously validated semi-automatic method; 450 radiomic features (RF) were extracted according to IBSI (Image Biomarker Standardization Initiative) guidelines. Only one model for cancer-specific survival (CSS) prediction was suitable to be independently tested, according to our criteria. This model, in addition to HPV status, SUVmean and SUVmax, included two independent meta-factors (F), resulting from combining selected RF clusters. In a subgroup of 66 patients with complete HPV information, the global risk score R was computed considering the original coefficients and was tested by Cox regression as predictive of CSS. Independently, only the radiomic risk score R derived from F was tested on the same subgroup to learn about the radiomics contribution to the model. The metabolic tumor volume (MTV) was also tested as a single predictor and its prediction performances were compared to the global and radiomic models. Finally, the validation of MTV and the radiomic score R were also tested on the entire dataset. Regarding the analysis of the subgroup with HPV information, with a median follow-up of 41.6 months, seven patients died due to cancer. R was confirmed to be associated to CSS (p value = 0.05) with a C-index equal 0.75 (95% CI=0.62-0.85). The best cut-off value (equal to 0.15) showed high ability in patient stratification (p=0.01, HR=7.4, 95% CI=1.6-11.4). The 5-year CSS for R were 97% (95% CI: 93-100%) vs 74% (56-92%) for low- and high-risk groups, respectively. R and MTV alone were also significantly associated to CSS for the subgroup with an almost identical C-index. According to best cut-off value (R > 0.12 and MTV > 15.5cc), the 5-year CSS were 96% (95% CI: 89-100%) vs 65% (36-94%) and 97% (95% CI: 88-100%) vs 77% (58-93%) for RF and MTV, respectively. Results regarding RF and MTV were confirmed in the overall group. A previously published PET radiomic model for CSS prediction was independently validated. Performances of the model were similar to the ones of using only the MTV, without improvement of prediction accuracy.
Availability note (English)
Available from: http://dx.doi.org/10.1007/s00259-022-06098-9Additional details
Identifiers
Publishing Information
- Journal Title
- European Journal of Nuclear Medicine and Molecular Imaging
- Journal Volume
- 50
- Journal Issue
- 5
- Journal Page Range
- p. 1329-1336
- ISSN
- 1619-7070
- CODEN
- EJNMA6
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 54050077
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ACCURACY; AUTOMATION; BIOLOGICAL MARKERS; CARCINOMAS; CHEMOTHERAPY; COMBINED THERAPY; DATA COMPILATION; FLUORINE 18; FLUORODEOXYGLUCOSE; HEAD; IMAGE PROCESSING; NECK; PHARYNX; POSITRON COMPUTED TOMOGRAPHY; RADIOMICS; RADIOPHARMACEUTICALS; RADIOTHERAPY; RECOMMENDATIONS; SURVIVAL CURVES; VALIDATION
- Descriptors DEC
- ANTIMETABOLITES; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; COMPUTERIZED TOMOGRAPHY; DATA; DATA PROCESSING; DIAGNOSTIC TECHNIQUES; DIGESTIVE SYSTEM; DISEASES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; FLUORINE ISOTOPES; HOURS LIVING RADIOISOTOPES; INFORMATION; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; MATERIALS; MEDICINE; NANOSECONDS LIVING RADIOISOTOPES; NEOPLASMS; NUCLEAR MEDICINE; NUCLEI; ODD-ODD NUCLEI; ORGANS; PROCESSING; RADIOACTIVE MATERIALS; RADIOISOTOPES; RADIOLOGY; RESPIRATORY SYSTEM; TESTING; THERAPY; TOMOGRAPHY
Optional Information
- Notes
- Preclinical Imaging